» Authors » Avgi Maloukou

Avgi Maloukou

Explore the profile of Avgi Maloukou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Simitsopoulou M, Roilides E, Maloukou A, Gil-Lamaignere C, Walsh T
Mycoses . 2008 Feb; 51(2):147-54. PMID: 18254752
The frequency of zygomycosis has increased considerably over recent years mainly in immunocompromised and diabetic patients. Little is known about the effects of host innate immunity against different Zygomycetes especially...
2.
Panagopoulou P, Filioti J, Farmaki E, Maloukou A, Roilides E
Infect Control Hosp Epidemiol . 2007 Jan; 28(1):60-7. PMID: 17230389
Objective: To evaluate filamentous fungi with respect to environmental load and potential drug resistance in a tertiary care teaching hospital. Design: Monthly survey in 2 buildings of the hospital during...
3.
Gil-Lamaignere C, Winn R, Simitsopoulou M, Maloukou A, Walsh T, Roilides E
Med Mycol . 2005 Jul; 43(3):253-60. PMID: 16010852
While Aspergillus spp. have been the most frequent filamentous fungi causing infections in immunocompromised patients, Scedosporium spp. are emerging as life-threatening pathogens. We studied the effects of interferon gamma (IFN-gamma)...
4.
Winn R, Gil-Lamaignere C, Roilides E, Simitsopoulou M, Lyman C, Maloukou A, et al.
Cytokine . 2005 Jun; 31(1):1-8. PMID: 15935692
Fusarium spp. and Scedosporium spp. have emerged as important fungal pathogens that are frequently resistant to antifungal compounds. We investigated the effects of human interleukin-15 (IL-15) on human polymorphonuclear leukocyte...
5.
Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn R, Walsh T
J Infect Dis . 2005 Mar; 191(7):1180-7. PMID: 15747255
Zygomycetes cause serious invasive infections, predominantly in immunocompromised and diabetic patients with poor prognoses and limited therapeutic options. We compared the antifungal function of human polymorphonuclear leukocytes (PMNLs) against hyphae...
6.
Winn R, Gil-Lamaignere C, Maloukou A, Roilides E
Med Mycol . 2004 Jan; 41(6):503-9. PMID: 14725324
Fusarium spp. are emerging as important causes of invasive fungal infections. They tend to have decreased susceptibility to antifungal agents, making host defences very important. The ability of human phagocytes...
7.
Gil-Lamaignere C, Roilides E, Lyman C, Simitsopoulou M, Stergiopoulou T, Maloukou A, et al.
Infect Immun . 2003 Oct; 71(11):6472-8. PMID: 14573669
Scedosporium apiospermum (Pseudallescheria boydii) is an emerging opportunistic filamentous fungus that causes serious infections in both immunocompetent and immunocompromised patients. To gain insight into the immunopathogenesis of infections due to...
8.
Winn R, Gil-Lamaignere C, Roilides E, Simitsopoulou M, Lyman C, Maloukou A, et al.
J Infect Dis . 2003 Aug; 188(4):585-90. PMID: 12898448
The effects of interleukin (IL)-15 on human polymorphonuclear leukocyte (PMNL) activity against Aspergillus fumigatus and Aspergillus flavus were investigated. Pretreatment with IL-15 for 2 h increased PMNL oxidative burst, as...
9.
Gil-Lamaignere C, Roilides E, Maloukou A, Georgopoulou I, Petrikkos G, Walsh T
J Antimicrob Chemother . 2002 Dec; 50(6):1027-30. PMID: 12461027
Scedosporium prolificans and Scedosporium apiospermum are resistant to most antifungal agents and cause refractory pulmonary and disseminated infections. The combined effects of deoxycholate amphotericin B, amphotericin B lipid complex and...
10.
Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh T
Antimicrob Agents Chemother . 2002 Jun; 46(7):2234-7. PMID: 12069979
Scedosporium prolificans and Scedosporium apiospermum (Pseudallescheria boydii) cause pulmonary and disseminated infections refractory to most currently used antifungal agents in immunocompromised patients. We therefore investigated the potential antifungal activities of...